Arcadia Biosciences (RKDA) Misses Q4 EPS by 298c

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($2.98). Revenue for the quarter came in at $1.22 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters